LECANEMAB RECEIVES PRIORITY REVIEW STATUS IN JAPAN
Go back to LECANEMAB RECEIVES PRIORITY REVIEW STATUS IN JAPAN| BIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 196.58 -2.09 (1.05%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $198.67 | 52 Week High | $333.65 | |||
| Open | $200.22 | 52 Week Low | $223.02 | |||
| Day High | $200.99 | P/E | 25.17 | |||
| Day Low | $193.20 | EPS | $7.81 | |||
| Volume | 1,729,827 | |||||
| Eisai Co Ltd American Depositary Shares (AMEX: ESALY) | Delayed: 61.51 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $61.51 | 52 Week High | $67.60 | |||
| Open | $49.73 | 52 Week Low | $53.55 | |||
| Day High | $61.51 | P/E | N/A | |||
| Day Low | $61.51 | EPS | $0.00 | |||
| Volume | 1,907,007 | |||||
